These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 29661626)

  • 1. Influence of an independent quarterly audit on publicly reported vancomycin-resistant enterocococi bacteremia data in Ontario, Canada.
    Prematunge C; Policarpio ME; Johnstone J; Adomako K; Nadolny E; Lam F; Li Y; Brown KA; Garber G
    Am J Infect Control; 2018 Sep; 46(9):1036-1040. PubMed ID: 29661626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient- and hospital-level predictors of vancomycin-resistant Enterococcus (VRE) bacteremia in Ontario, Canada.
    Johnstone J; Chen C; Rosella L; Adomako K; Policarpio ME; Lam F; Prematunge C; Garber G;
    Am J Infect Control; 2018 Nov; 46(11):1266-1271. PubMed ID: 29903421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany - 10 years of surveillance.
    Remschmidt C; Schröder C; Behnke M; Gastmeier P; Geffers C; Kramer TS
    Antimicrob Resist Infect Control; 2018; 7():54. PubMed ID: 29760912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysis.
    Mac S; Fitzpatrick T; Johnstone J; Sander B
    Antimicrob Resist Infect Control; 2019; 8():168. PubMed ID: 31687132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Multicenter Analysis of Outcomes After Cessation of Control Measures for Vancomycin-Resistant Enterococci.
    Lemieux C; Gardam M; Evans G; John M; Suh KN; vanWalraven C; Vicencio E; Coulby C; Roth V; Hota S
    Infect Control Hosp Epidemiol; 2017 Jan; 38(1):24-30. PubMed ID: 27804901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of vancomycin-resistant enterococci (VRE)-associated morbidity following relaxation of VRE screening and isolation precautions in a tertiary care hospital.
    Popiel KY; Miller MA
    Infect Control Hosp Epidemiol; 2014 Jul; 35(7):818-25. PubMed ID: 24915209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of vancomycin-resistant enterococci colonization in critically ill pediatric patients.
    Sutcu M; Akturk H; Acar M; Salman N; Aydın D; Akgun Karapınar B; Ozdemir A; Cihan R; Citak A; Somer A
    Am J Infect Control; 2016 May; 44(5):515-9. PubMed ID: 26781220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies.
    Gedik H; Yıldırmak T; Simşek F; Kantürk A; Arıca D; Aydın D; Yokuş O; Demirel N; Arabacı C
    J Infect Dev Ctries; 2014 Sep; 8(9):1113-8. PubMed ID: 25212075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of healthcare-associated infection surveillance in smaller Australian hospitals.
    Hoskins AJ; Worth LJ; Imam N; Johnson SA; Bull AL; Richards MJ; Bennett NJ
    J Hosp Infect; 2018 May; 99(1):85-88. PubMed ID: 29031863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory-identified vancomycin-resistant enterococci bacteremia incidence: A standardized infection ratio prediction model.
    Tanwar SSS; Weiner-Lastinger LM; Bell JM; Allen-Bridson K; Bagchi S; Dudeck MA; Edwards JR
    Infect Control Hosp Epidemiol; 2022 Jun; 43(6):714-718. PubMed ID: 34085620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients.
    Salgado CD
    Am J Infect Control; 2008 Dec; 36(10):S175.e5-8. PubMed ID: 19084155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discontinuing Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) Is Associated With Rising VRE Bloodstream Infection Rates in Ontario Hospitals, 2009-2018: A Quasi-experimental Study.
    Johnstone J; Shing E; Saedi A; Adomako K; Li Y; Brown KA; Garber G
    Clin Infect Dis; 2020 Oct; 71(7):1756-1759. PubMed ID: 31922536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
    Hefazi M; Damlaj M; Alkhateeb HB; Partain DK; Patel R; Razonable RR; Gastineau DA; Al-Kali A; Hashmi SK; Hogan WJ; Litzow MR; Patnaik MM
    Transpl Infect Dis; 2016 Dec; 18(6):913-920. PubMed ID: 27642723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Horizontal infection prevention measures and a risk-managed approach to vancomycin-resistant enterococci: An evaluation.
    Bryce E; Grant J; Scharf S; Dempster L; Lau TT; Laing F; Shajari S; Forrester L
    Am J Infect Control; 2015 Nov; 43(11):1238-43. PubMed ID: 26190379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of discontinuing single-room isolation of patients with vancomycin-resistant enterococci: a quasi-experimental single-centre study in South Korea.
    Park S; Bae S; Kim EO; Chang E; Kim MJ; Chong YP; Choi SH; Lee SO; Kim YS; Jung J; Kim SH
    J Hosp Infect; 2024 May; 147():77-82. PubMed ID: 38492645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of temporal clusters and risk factors of bacteremia by nosocomial vancomycin-resistant enterococci.
    da Silva NS; Muniz VD; Estofolete CF; Furtado GH; Rubio FG
    Am J Infect Control; 2014 Apr; 42(4):389-92. PubMed ID: 24679566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Has improved hand hygiene compliance reduced the risk of hospital-acquired infections among hospitalized patients in Ontario? Analysis of publicly reported patient safety data from 2008 to 2011.
    DiDiodato G
    Infect Control Hosp Epidemiol; 2013 Jun; 34(6):605-10. PubMed ID: 23651891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic burden of nosocomial infections caused by vancomycin-resistant enterococci.
    Puchter L; Chaberny IF; Schwab F; Vonberg RP; Bange FC; Ebadi E
    Antimicrob Resist Infect Control; 2018; 7():1. PubMed ID: 29312658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of vancomycin-resistant
    Cho SY; Kim HM; Chung DR; Choi JR; Lee MA; Huh HJ; Lee NY; Huh K; Kang CI; Peck KR
    Infect Control Hosp Epidemiol; 2022 May; 43(5):603-608. PubMed ID: 33993892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci.
    Zaas AK; Song X; Tucker P; Perl TM
    Clin Infect Dis; 2002 Nov; 35(10):1139-46. PubMed ID: 12410472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.